Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Operating Leases (2019 - 2025)

Vycor Medical has reported Operating Leases over the past 7 years, most recently at $52221.0 for Q4 2025.

  • Quarterly Operating Leases changed 0.0% to $52221.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52221.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $52221.0 for FY2025, 0.0% changed from the prior year.
  • Operating Leases was $52221.0 for Q4 2025 at Vycor Medical, up from $13566.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $111922.0 in Q3 2023 and troughed at $4280.0 in Q2 2023.
  • The 5-year median for Operating Leases is $48410.5 (2022), against an average of $49462.6.
  • Year-over-year, Operating Leases plummeted 88.93% in 2022 and then soared 1695.72% in 2024.
  • A 5-year view of Operating Leases shows it stood at $30580.0 in 2021, then decreased by 3.23% to $29591.0 in 2022, then surged by 239.22% to $100379.0 in 2023, then tumbled by 47.98% to $52221.0 in 2024, then changed by 0.0% to $52221.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Operating Leases are $52221.0 (Q4 2025), $13566.0 (Q3 2025), and $26700.0 (Q2 2025).